These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 16416154
21. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G, AstraZeneca Arthroplasty Study Group. Arch Intern Med; 2001 Oct 08; 161(18):2215-21. PubMed ID: 11575978 [Abstract] [Full Text] [Related]
22. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW. Ann Intern Med; 2002 Oct 15; 137(8):648-55. PubMed ID: 12379064 [Abstract] [Full Text] [Related]
23. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism. Wåhlander K, Eriksson H, Lundström T, Billing Clason S, Wall U, Nyström P, Wessman P, Schulman S, THRIVE III Investigators. Br J Haematol; 2006 Apr 15; 133(1):68-77. PubMed ID: 16512831 [Abstract] [Full Text] [Related]
24. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C, Mouret P. Semin Vasc Med; 2005 Aug 15; 5(3):266-75. PubMed ID: 16123914 [Abstract] [Full Text] [Related]
25. [Ximelagatran for treatment of venous thromboembolism]. Harenberg J, Fenyvesi T, Jörg I. Hamostaseologie; 2002 Aug 15; 22(3):25-9. PubMed ID: 12215758 [Abstract] [Full Text] [Related]
26. Ximelagatran in orthopaedic surgery. Eriksson B. Pathophysiol Haemost Thromb; 2005 Aug 15; 34 Suppl 1():10-7. PubMed ID: 15812199 [Abstract] [Full Text] [Related]
30. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy. Prescrire Int; 2005 Aug 15; 14(78):127-32. PubMed ID: 16106594 [Abstract] [Full Text] [Related]
36. Ximelagatran: an oral direct thrombin inhibitor. Dager WE, Vondracek TG, McIntosh BA, Nutescu EA. Ann Pharmacother; 2004 Nov 15; 38(11):1881-97. PubMed ID: 15383641 [Abstract] [Full Text] [Related]
37. Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran. Eriksson H. Drugs; 2004 Nov 15; 64 Suppl 1():37-46. PubMed ID: 15586626 [Abstract] [Full Text] [Related]
38. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Olsson SB, Executive Steering Committee of the SPORTIF III Investigators. Lancet; 2003 Nov 22; 362(9397):1691-8. PubMed ID: 14643116 [Abstract] [Full Text] [Related]
39. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. Wu C, Alotaibi GS, Alsaleh K, Linkins LA, McMurtry MS. Thromb Res; 2015 Feb 22; 135(2):243-8. PubMed ID: 25488466 [Abstract] [Full Text] [Related]